3 completed, 1 recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Chronic Phase Chronic Myeloid Leukemia: new trials by email Literature Review of Chronic Phase Chronic Myeloid Leukemia trials Research Report on Chronic Phase Chronic Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors Ponatinib - Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia | Phase 1 / Phase 2 | Recruiting | Incyte Biosciences International Sàrl | 70 | 2020-01-29 | 2026-10-09 |
| Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response P1101 - Chronic Phase Chronic Myeloid Leukemia | Phase 1 | Completed | Arbeitsgemeinschaft medikamentoese Tumortherapie | 12 | 2013-08-30 | 2019-01-04 |
| Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia Nilotinib, Ruxolitinib - Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 4 | 2013-08-01 | 2020-11-02 |
| Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients Nilotinib, Ruxolitinib - Chronic Phase Chronic Myeloid Leukemia | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 11 | 2013-02-21 | 2021-01-05 |
Leukemia, Myeloid, Chronic-Phase (4) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3) · Blast Crisis (2) · Leukemia, Myeloid, Accelerated Phase (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1)
Bone Marrow Diseases (4) · Chronic Disease (4) · Disease Attributes (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia, Myeloid (4) · Myeloproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Leukemia (3) · Carcinogenesis (2) · Cell Transformation, Neoplastic (2) · Immune System Diseases (2)
nilotinib (2) · ruxolitinib (2) · peginterferon alfa-2b (1) · ponatinib (1)
Arbeitsgemeinschaft medikamentoese Tumortherapie (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Incyte Biosciences International Sàrl (1) · University Health Network, Toronto (1)
Austria (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Dennis Kim, MD/PhD (1) · Josef Thaler, MD (1) · Kendra Sweet, M.D. (1) · Mohammed-El-Amine Bensmaine, MD (1)
2018 (1), 2023 (1)